ArticleScience translational medicine2022

Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.

Kunle Odunsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.